Treos Bio Company
Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.
Technology:
Peptides and Proteins
Industry:
Deep diagnostics
Headquarters:
London, England, United Kingdom
Founded Date:
2013-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
$38,363,455.00
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-03-31
Last Funding Type:
Convertible Note
Register and Claim Ownership